Class IIITerminated in FDA datasetRecall initiated Nov 17, 2014

Nutri-Dyn, 5-HTP Extra Strength, Pharmaceutical Grade from Switzerland, Dietary Supplement 60…

Recalling firm: Nutri-Dyn Midwest, Inc.

Why it was recalled

Nutri-Dyn has initiated a recall due to mislabeling. During production of CoQ-10, Lot #140186, one or more bottles were mistakenly labeled as 5-HTP Extra Strength.

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Jun 3, 2015.

Check your package

Compare the exact product and package details with the label you have.

ProductNutri-Dyn, 5-HTP Extra Strength, Pharmaceutical Grade from Switzerland, Dietary Supplement 60 capsules in plastic bottle, 5-Hydroxytryptophan (5-HTP) 200 mg., Other Ingredients: Rice flour, magnesium stearate, and silica, UPC # 6 96859 02947 9, Sku # R200E.
UPC696859029479

FDA code information

Lot # 14086

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Nutri-Dyn, 5-HTP Extra Strength, Pharmaceutical Grade from Switzerland, Dietary Supplement 60 capsules in plastic bottle, 5-Hydroxytryptophan (5-HTP) 200 mg., Other Ingredients: Rice flour, magnesium stearate, and silica, UPC # 6 96859 02947 9, Sku # R200E.

Extracted codes and context

TypeCode / valueContext
UPC696859029479 200 mg., Other Ingredients: Rice flour, magnesium stearate, and silica, UPC # 6 96859 02947 9, Sku # R200E.
lot14086Lot # 14086

Original FDA recall reason

Nutri-Dyn has initiated a recall due to mislabeling. During production of CoQ-10, Lot #140186, one or more bottles were mistakenly labeled as 5-HTP Extra Strength.

Recall details

Recall number
F-1922-2015
Event ID
69933
FDA status
Terminated
Initiated
Nov 17, 2014
Reported
Apr 15, 2015
Classified
Apr 7, 2015
Terminated
Jun 3, 2015
Quantity
1,627 bottles
Location
Maple Plain, MN, United States
Initiation type
Voluntary: Firm initiated
Notification
Letter

Where it was distributed

US: AZ, CO, IA, IN, MI, MN, MT, MD, NJ, NY, SD, TX, WI. OUS: ISRAEL

FDA source record · F-1922-2015

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.